ADVFN Logo
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

MDGL Madrigal Pharmaceuticals Inc

205.25
0.00 (0.00%)
Pre Market
Last Updated: 04:00:01
Delayed by 15 minutes

Income Statement

Balance Sheet

Cash Flow

Quarter End Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023
USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)
Total Revenue 00000000
Operating Income -57.59M-70.27M-80.41M-85.3M-78.34M-86.45M-98.53M-117.18M
Pre Tax Income -57.52M-70.73M-81.2M-85.91M-76.9M-85.8M-98.74M-112.19M
Net Income -57.52M-70.73M-81.2M-85.91M-76.9M-85.8M-98.74M-112.19M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) 00000000
EBIT -57.59M-70.27M-80.41M-85.3M-78.34M-86.45M-98.53M-117.18M
EBITDA -57.48M-70.16M-80.29M-85.17M-78.21M-86.32M-98.4M-117.03M
Year End December 30 2023 20162017201820192020202120222023
USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)
Total Revenue 00000000
Operating Income -25.22M-32.06M-40.68M-94.97M-206.67M-242.48M-293.57M-380.5M
Pre Tax Income -26.39M-31.15M-32.81M-83.95M-202.24M-241.85M-295.35M-373.63M
Net Income -26.39M-31.15M-32.81M-83.95M-202.24M-241.85M-295.35M-373.63M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) -2.208-1.923-1.888-4.825-11.571-12.68-14.714-17.208
EBIT -25.22M-31.71M-40.48M-94.97M-206.57M-242.21M-293.57M-380.5M
EBITDA -25.22M-31.99M-40.59M-94.86M-206.2M-242.08M-293.1M-379.97M